Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ISIS-FGFR4Rx
print preview
bookmark
share with colleague
General Information
Company
Isis Pharmaceuticals Inc.
Description
Inhibitor of fibroblast growth factor receptor 4 (FGFR4)
Molecular Target
Fibroblast growth factor (FGF) receptor 4 (FGFR4) (CD334)
Mechanism of Action
Antisense therapy; Fibroblast growth factor (FGF) receptor antagonist
Latest Stage of Development
Phase I
Indication
Obesity
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy